XenoPort, Inc. (NASDAQ:XNPT)

CAPS Rating: 2 out of 5

A biopharmaceutical company focused on developing a portfolio of internally discovered product candidates that utilize the body's natural nutrient transporter mechanisms to improve the therapeutic benefits of drugs.

Recs

0
Player Avatar acts20 (37.40) Submitted: 10/19/2011 1:27:07 PM : Outperform Start Price: $5.40 XNPT Score: +1.05

At low witth aproved drug

Featured Broker Partners


Advertisement